Cronos Group (CRON) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 30, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CRON SEC filings page.
Cronos Group Inc. (CRON) reported $179.1M in revenue over the twelve months to Jun 30, 2026, up 37.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue growth is now translating into much better gross margins, but reinvestment absorbs nearly all operating cash.
The swing from net income of$41.1M in FY2024 to a net loss of$9.4M in FY2025 contrasts with the operating picture. Operating cash flow instead increased from$18.8M to$25.9M , making the bottom line a poor shorthand for cash generated by the business across these years.
Gross margin reached
Receivables grew
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Cronos Group Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Cronos Group Inc. held $839.5M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $25.9M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Cronos Group Inc. scores 87/100 among other emerging companies.
Cronos Group Inc. had 379M shares outstanding at the end of fiscal year 2025, against 383M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Cronos Group Inc. scores 74/100 among other emerging companies.
Cronos Group Inc. spent $4.4M on research and development in fiscal year 2025, which was 2.7% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Cronos Group Inc. scores 17/100 among other emerging companies.
Cronos Group Inc. reported revenue of $146.6M in fiscal year 2025, against $117.6M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Cronos Group Inc. scores 71/100 among other emerging companies.
Cronos Group Inc.'s operations generated $25.9M of cash in fiscal year 2025, against $18.8M generated in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Cronos Group Inc. scores 95/100 among other emerging companies.
Cronos Group Inc.'s cash, cash equivalents and investments came to $839.5M at the end of fiscal year 2025, against $54.2M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Cronos Group Inc. scores 99/100 among other emerging companies.
Cronos Group Inc. scores 14.96, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $1.2B against total liabilities of $54.2M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Cronos Group Inc. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.
Cronos Group Inc. reported a net loss of $9.4M while generating $25.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Cronos Group Inc. generated $53.0M in revenue in Q2 2026. This represents an increase of 58.4% from the same quarter a year earlier. Against the prior quarter it is up 17.2%.
Cronos Group Inc.'s EBITDA was $10.8M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 469.1%.
Cronos Group Inc. reported $32.1M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 133.3%.
Cronos Group Inc. earned $0.09 per diluted share (EPS) in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 125.0%.
Cash & Balance Sheet
Cronos Group Inc. generated $22.3M in free cash flow in Q2 2026, representing cash available after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 146.8%.
Cronos Group Inc. held $467.0M in cash as of Q2 2026; no long-term debt figure is on record for that period.
Not reported for Q2 2026.
Margins & Returns
Cronos Group Inc.'s gross margin was 53.7% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 10.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.3 percentage points.
Cronos Group Inc.'s operating margin was 14.0% in Q2 2026, reflecting core business profitability. This is up 29.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 18.0 percentage points.
Cronos Group Inc.'s net profit margin was 60.5% in Q2 2026, showing the share of revenue converted to profit. Against the prior quarter it is up 30.1 percentage points. No change is given against Q2 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Cronos Group Inc.'s quarterly ROE was 3.0% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 6.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.
Capital Allocation
Cronos Group Inc. invested $1.2M in research and development in Q2 2026. This represents an increase of 30.8% from the same quarter a year earlier. Against the prior quarter it is down 14.0%.
Cronos Group Inc. spent $16.1M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 346.5% from the same quarter a year earlier. Against the prior quarter it is down 3.6%.
Cronos Group Inc. invested $1.7M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 54.7% from the same quarter a year earlier. Against the prior quarter it is down 7.3%.
CRON Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $53.0M+58.4% | $45.2M+40.1% | $44.5M+47.0% | $36.3M+6.1% | $33.5M+20.5% | $32.3M+27.6% | $30.3M+26.7% | $34.3M+38.1% |
| Gross Profit | $28.5M+96.2% | $19.2M+39.5% | $16.2M+49.8% | $18.3M+407.7% | $14.5M+130.3% | $13.7M+206.4% | $10.8M+464.9% | $3.6M-9.0% |
| R&D Expenses | $1.2M+30.8% | $1.4M+78.2% | $1.4M+34.4% | $1.3M+8.3% | $929K-3.4% | $793K-20.5% | $1.0M-29.2% | $1.2M-0.3% |
| SG&A Expenses | $17.6M+10.7% | $17.4M+25.1% | $19.5M+5.2% | $14.6M-20.4% | $15.9M-7.1% | $13.9M-2.6% | $18.5M+14.4% | $18.3M-7.0% |
| Operating Income | $7.4Mn/m | -$1.8Mn/m | -$7.5Mn/m | -$503Kn/m | -$5.3Mn/m | -$4.1Mn/m | -$11.4Mn/m | -$33.7Mn/m |
| EBITDA | $10.8Mn/m | $1.9Mn/m | -$3.8Mn/m | $3.0Mn/m | -$1.1Mn/m | -$1.2Mn/m | -$8.8Mn/m | -$30.1Mn/m |
| Income Tax | $51Kn/m | $2.4Mn/m | -$11.9M-693.6% | -$1.3Mn/m | -$525Kn/m | -$455Kn/m | $2.0Mn/m | -$2.7Mn/m |
| Net Income | $32.1Mn/m | $13.8M+124.6% | -$1.8M-104.2% | $26.0M+210.9% | -$39.7Mn/m | $6.1Mn/m | $43.7Mn/m | $8.3Mn/m |
| EPS (Basic) | $0.09n/m | $0.04+100.0% | $0.00-100.0% | $0.07+250.0% | -$0.10n/m | $0.02n/m | $0.12n/m | $0.02n/m |
| EPS (Diluted) | $0.09n/m | $0.04+100.0% | $0.00-100.0% | $0.07+250.0% | -$0.10n/m | $0.02n/m | $0.12n/m | $0.02n/m |
| Diluted Shares (Avg) | 375M-2.7% | 382M-1.3% | N/A | 385M-0.3% | 385M+0.8% | 387M+1.4% | N/A | 386M+1.3% |
Not reported in any period shown, so not listed: Cost of Revenue, Interest Expense.
CRON Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.2B+0.4% | $1.2B+1.6% | $1.2B+2.6% | $1.2B-0.5% | $1.2B+7.7% | $1.2B+4.1% | $1.2B+2.3% | $1.2B+3.0% |
| Current Assets | $912.0M-1.6% | $927.9M+1.0% | $944.1M+0.9% | $922.2M-3.9% | $927.1M-0.9% | $918.6M-2.5% | $936.1M+0.3% | $959.2M+4.4% |
| Cash & Equivalents | $467.0M-41.2% | $821.9M+3.0% | $791.8M-7.8% | $784.2M-9.0% | $794.4M-6.3% | $797.8M-6.7% | $858.8M+28.3% | $862.0M+50.8% |
| Short-Term Investments | $330.0M+725.0% | $0-100.0% | $40.0Mn/m | $40.0Mn/m | $40.0Mn/m | $40.0Mn/m | $0-100.0% | $0-100.0% |
| Inventory | $52.7M+25.1% | $48.7M+40.7% | $46.8M+41.0% | $48.2M+1.9% | $42.1M+44.4% | $34.6M+12.9% | $33.1M+8.7% | $47.3M+31.8% |
| Accounts Receivable | $36.7M+37.9% | $33.0M+76.1% | $34.1M+120.5% | $27.1M+32.3% | $26.6M+64.5% | $18.7M+22.0% | $15.5M+10.6% | $20.5M+30.2% |
| Long-Term Investments | $4.5M+101.1% | $5.2M+88.7% | $7.7M+172.4% | $11.4M+294.6% | $2.3M-28.9% | $2.8M-86.1% | $2.8M-92.0% | $2.9M-95.3% |
| Goodwill | $64.1M-4.1% | $65.4M+3.4% | $66.5M+4.8% | $65.4M+72.0% | $66.9M+6435.0% | $63.3M+6012.9% | $63.5M+5903.1% | $38.0M+3588.5% |
| Total Liabilities | $62.4M+38.6% | $48.3M+23.6% | $54.2M-2.1% | $46.4M-12.2% | $45.0M+27.7% | $39.1M+9.2% | $55.3M+25.3% | $52.8M+58.4% |
| Current Liabilities | $56.4M+49.9% | $42.4M+28.4% | $48.2M-3.0% | $41.1M+3.8% | $37.6M+13.8% | $33.0M-1.1% | $49.7M+20.1% | $39.6M+29.4% |
| Non-Current Liabilities | $6.1M-18.3% | $5.9M-2.3% | $6.0M+6.5% | $5.3M-60.1% | $7.4M+236.9% | $6.0M+157.2% | $5.6M+105.2% | $13.3M+379.8% |
| Total Equity | $1.1B-1.3% | $1.1B+0.7% | $1.1B+2.8% | $1.1B+0.1% | $1.1B+2.2% | $1.1B-0.9% | $1.1B-3.2% | $1.1B-3.4% |
| Retained Earnings | $492.3M+16.1% | $460.5M-0.7% | $447.8M-2.2% | $450.0M+8.7% | $424.1M+4.5% | $463.8M+11.9% | $457.7M+9.8% | $414.0M-10.3% |
Not reported in any period shown, so not listed: Long-Term Debt.
CRON Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $24.0M+752.0% | $10.9Mn/m | $11.8M+53.3% | $13.3M+14.9% | $2.8M+61.6% | -$2.1Mn/m | $7.7M-54.1% | $11.6Mn/m |
| Depreciation & Amortization | $3.4M-19.7% | $3.7M+31.2% | $3.7M+44.8% | $3.5M-1.0% | $4.2M+177.7% | $2.8M+64.1% | $2.5M+114.5% | $3.6M+66.1% |
| Stock-Based Compensation | $1.6M+12.7% | $1.3M-37.1% | N/A | $2.3M+3.1% | $1.4M-38.2% | $2.1M+3.6% | N/A | $2.3M+15.6% |
| Capital Expenditures | $1.7M-54.7% | $1.9M-87.7% | $2.1M-39.6% | $4.5M-30.1% | $3.8M+426.3% | $15.3M+785.0% | $3.5M+190.9% | $6.4M |
| Free Cash Flow | $22.3Mn/m | $9.0Mn/m | $9.7M+132.1% | $8.8M+70.8% | -$1.0M-200.4% | -$17.4Mn/m | $4.2M-73.2% | $5.2M |
| Investing Cash Flow | -$358.3Mn/m | $38.0Mn/m | $2.8Mn/m | -$23.0Mn/m | -$983Kn/m | -$55.4M-129.2% | -$5.0M-106.1% | -$818K-100.5% |
| Financing Cash Flow | -$20.9Mn/m | -$18.3Mn/m | -$7.4Mn/m | -$1.9Mn/m | -$7.7Mn/m | -$2.9Mn/m | -$313Kn/m | -$13Kn/m |
| Share Buybacks | $16.1M+346.5% | $16.7Mn/m | $4.3Mn/m | $1.9Mn/m | $3.6M | $0 | $0 | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
CRON Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.7%+10.3pp | 42.4%-0.2pp | 36.4%+0.7pp | 50.4%+39.9pp | 43.4%+20.7pp | 42.6%+24.8pp | 35.7%+27.7pp | 10.5%-5.5pp |
| Operating Margin | 14.0%+29.9pp | -4.0%+8.6pp | -16.8%+20.7pp | -1.4%+96.8pp | -15.9%+40.1pp | -12.6%+50.5pp | -37.5%+53.0pp | -98.2%-10.4pp |
| Net Margin | 60.5% | 30.4%+11.4pp | -4.1% | 71.4%+47.1pp | -118.7% | 19.0%+27.8pp | 144.3% | 24.4%+31.0pp |
| Return on Equity | 3.0%+6.7pp | 1.3%+0.7pp | -0.2%-4.3pp | 2.4%+1.6pp | -3.7%-2.8pp | 0.6%+0.8pp | 4.1%+8.2pp | 0.8%+0.9pp |
| Return on Assets | 2.7%+6.1pp | 1.2%+0.6pp | -0.1%-3.9pp | 2.2%+1.5pp | -3.4%-2.6pp | 0.5%+0.7pp | 3.8%+7.7pp | 0.7%+0.9pp |
| Current Ratio | 16.18-8.5x | 21.87-5.9x | 19.59+0.8x | 22.45-1.8x | 24.65-3.6x | 27.80-0.4x | 18.84-3.7x | 24.24-5.8x |
| Liabilities-to-Equity | 0.060.0x | 0.040.0x | 0.050.0x | 0.040.0x | 0.040.0x | 0.040.0x | 0.050.0x | 0.050.0x |
| Asset Turnover | 0.040.0x | 0.040.0x | 0.040.0x | 0.030.0x | 0.030.0x | 0.030.0x | 0.030.0x | 0.030.0x |
| FCF Margin | 42.0%+45.1pp | 20.0%+73.8pp | 21.8%+8.0pp | 24.3%+9.2pp | -3.0%-6.7pp | -53.8%-38.3pp | 13.8%-51.4pp | 15.1% |
Not reported in any period shown, so not listed: Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Cronos Group Inc. CRON | FY2025 | $146.6M | -$9.4M | -6.4% | $1.2B | 74/100 |
| Tilray Brands, Inc. TLRY | FY2026 | $915.5M | -$121.4M | -13.3% | $390.2M | 41/100 |
| Evotec SE EVO | FY2024 | $824.9M | -$203.0M | -24.6% | $561.5M | 35/100 |
| Pacira BioSciences, Inc. PCRX | FY2025 | $726.4M | $7.0M | 1.0% | $1.5B | 52/100 |
| Akebia Therapeutics, Inc. AKBA | FY2025 | $236.2M | -$5.3M | -2.3% | $205.7M | 49/100 |
Where Cronos Group Inc. Ranks
Frequently Asked Questions
What is Cronos Group Inc.'s annual revenue?
Cronos Group Inc. (CRON) reported $146.6M in total revenue for fiscal year 2025. This represents a 24.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Cronos Group Inc.'s revenue growing?
Cronos Group Inc. (CRON) revenue grew by 24.6% year-over-year, from $117.6M to $146.6M in fiscal year 2025.
Is Cronos Group Inc. profitable?
Yes, Cronos Group Inc. (CRON) reported a net income of $70.0M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $9.4M, with a net profit margin of -6.4%.
What is Cronos Group Inc.'s EBITDA?
Cronos Group Inc. (CRON) had EBITDA of -$3.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Cronos Group Inc.'s gross margin?
Cronos Group Inc. (CRON) had a gross margin of 42.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Cronos Group Inc.'s operating margin?
Cronos Group Inc. (CRON) had an operating margin of -11.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Cronos Group Inc.'s net profit margin?
Cronos Group Inc. (CRON) had a net profit margin of -6.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Cronos Group Inc.'s return on equity (ROE)?
Cronos Group Inc. (CRON) has a return on equity of -0.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Cronos Group Inc.'s free cash flow?
Cronos Group Inc. (CRON) generated $149K in free cash flow during fiscal year 2025. This represents a -97.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Cronos Group Inc.'s operating cash flow?
Cronos Group Inc. (CRON) generated $25.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Cronos Group Inc.'s total assets?
Cronos Group Inc. (CRON) had $1.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Cronos Group Inc.'s capital expenditures?
Cronos Group Inc. (CRON) invested $25.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Cronos Group Inc. spend on research and development?
Cronos Group Inc. (CRON) invested $4.4M in research and development during fiscal year 2025.
What is Cronos Group Inc.'s current ratio?
Cronos Group Inc. (CRON) had a current ratio of 19.59 as of fiscal year 2025, which is generally considered healthy.
What is Cronos Group Inc.'s liabilities-to-equity ratio?
Cronos Group Inc. (CRON) had a liabilities-to-equity ratio of 0.05 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
What is Cronos Group Inc.'s return on assets (ROA)?
Cronos Group Inc. (CRON) had a return on assets of -0.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Cronos Group Inc.'s P/E ratio?
Cronos Group Inc. (CRON) trades at 17.4x earnings, its market capitalization divided by $70.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $1.2B as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Cronos Group Inc.'s price-to-sales ratio?
Cronos Group Inc. (CRON) trades at 6.8x sales, its market capitalization divided by $179.1M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.2B as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Cronos Group Inc.'s Altman Z-Score?
Cronos Group Inc. (CRON) has an Altman Z-Score of 14.96, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Cronos Group Inc.'s Piotroski F-Score?
Cronos Group Inc. (CRON) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Cronos Group Inc.'s earnings high quality?
Cronos Group Inc. (CRON) reported a net loss of $9.4M while generating $25.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Cronos Group Inc.?
Cronos Group Inc. (CRON) scores 74 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.